Re: [oss-security] Xen Security Advisory 407 v1 (CVE-2022-23816,CVE-2022-23825,CVE-2022-29900) - Retbleed - arbitrary speculative code execution with return instructions

[Salvatore Bonaccorso <carnil@xxxxxxxxxx>]

Hi,

On Tue, Jul 12, 2022 at 04:36:10PM +0000, Xen.org security team wrote:
> -----BEGIN PGP SIGNED MESSAGE-----
> Hash: SHA256
> 
>  Xen Security Advisory CVE-2022-23816,CVE-2022-23825,CVE-2022-29900 / XSA-407
> 
>    Retbleed - arbitrary speculative code execution with return instructions
> 
> ISSUE DESCRIPTION
> =================
> 
> Researchers at ETH Zurich have discovered Retbleed, allowing for
> arbitrary speculative execution in a victim context.
> 
> For more details, see:
>   https://comsec.ethz.ch/retbleed
> 
> ETH Zurich have allocated CVE-2022-29900 for AMD and CVE-2022-29901 for
> Intel.
> 
> Despite the similar preconditions, these are very different
> microarchitectural behaviours between vendors.
> 
> On AMD CPUs, Retbleed is one specific instance of a more general
> microarchitectural behaviour called Branch Type Confusion.  AMD have
> assigned CVE-2022-23816 (Retbleed) and CVE-2022-23825 (Branch Type
> Confusion).
> 
> For more details, see:
>   https://www.amd.com/en/corporate/product-security/bulletin/amd-sb-1037

Is it confirmed that AMD is not using CVE-2022-29900? The above
amd-sb-1037 references as well both CVE-2022-23825 (Branch Type
Confusion) and CVE-2022-29900 (RETbleed), so I assume they agreed to
use CVE-2022-29900 for retbleed?

So should the Xen advisory as well use CVE-2022-23825,CVE-2022-29900
and CVE-2022-29901?

Regards,
Salvatore